Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and immunogenicity of a human cytomegalovirus vaccine in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• VBI Vaccines Inc. Candidate Cytomegalovirus Vaccine

Snippet

Sponsor: VBI Vaccines Inc. | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-04-20